Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00984451 · ClinicalTrials.gov registry record
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
A clinical trial, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Completed
- Registry status
- 102
- Enrollment target
NCT00984451 is a clinical trial that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 102 participants.
The verdict
NCT00984451 has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- COMPLETED
- Registry status
- 102 participants
- Enrollment target
Study Summary
Background: * The influenza A virus can cause infections that lead to fever, cough, muscle aches, diarrhea, and headaches, and can even be fatal in some people. Seasonal influenza kills an estimated 36,000 people in the United States each year. In addition, more than 200,000 people are hospitalized for flu-related complications. Influenza A has a substantial health effect on every age group. * Currently, treatments are available for influenza A, but there is concern that the rate of complications or even death from this infection is still high despite treatment, and that over time this virus may become resistant to these treatments. Researchers are interested in developing a possible new treatment that uses antibodies against influenza A virus. Objectives: \- To collect plasma (the liquid component of blood containing antibodies) from people who have high levels of antibodies against the influenza A virus because they either have been previously infected with the virus or have been vaccinated against the infection. Eligibility: * Healthy male volunteers between 18 and 60 years of age who are eligible to donate blood. * Individuals must have previously either recovered from influenza infection or have been vaccinated against the infection, and may be subject to other restrictions on participating in National Institutes of Health research studies. Design: * Volunteers will undergo apheresis, an outpatient procedure in which researchers will collect plasma containing antibodies against the influenza virus by drawing blood into a special machine that separates blood cells from the liquid portion under sterile conditions and then returns the blood cells to the donor. * Volunteers will be screened with blood tests to ensure that they are eligible to participate and donate blood. * Volunteers are asked to undergo at least 3 sessions of apheresis; if willing, they can volunteer to participate in up to 20 sessions. * After plasma is collected, it will be tested to ens
Interventions
- BIOLOGICAL Plasma collection following infection or vaccination with influenza A
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 102 participants |
| Start Date | 2009-09 |
| Est. Completion | 2018-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00984451
The ClinicalTrials.gov registry entry for NCT00984451 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 102 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Plasma collection following infection or vaccination with influenza A is the first listed.
NCT00984451 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00984451 about?
NCT00984451 is a clinical study titled "A Pilot Study for Collection of Anti-Influenza A Immune Plasma". Background: * The influenza A virus can cause infections that lead to fever, cough, muscle aches, diarrhea, and headaches, and can even be fatal in some people. Seasonal influenza kills an estimated 36,000 people in the United States each year. In addition, more than 200,000 people are hospitalized...
What is the current status of trial NCT00984451?
This trial is currently completed. The enrollment target is 102 participants. The study started on 2009-09. Estimated completion is 2018-12.
What interventions are being tested in trial NCT00984451?
The interventions under investigation include: Plasma collection following infection or vaccination with influenza A (BIOLOGICAL).
Who is sponsoring clinical trial NCT00984451?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.